Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology
Fingerprint
Dive into the research topics where Marina Kremyanskaya is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Diagnosis and Treatment of Polycythemia Vera: A Review
Tremblay, D., Kremyanskaya, M., Mascarenhas, J. & Hoffman, R., 14 Jan 2025, In: JAMA - Journal of the American Medical Association. 333, 2, p. 153-160 8 p.Research output: Contribution to journal › Review article › peer-review
9 Scopus citations -
Venetoclax in combination with hypomethylating agents in chronic myelomonocytic leukemia: a propensity score matched multicenter cohort study: MYELODYSPLASTIC NEOPLASM
Tremblay, D., Csizmar, C., DiNardo, C. D., Ball, S., Rippel, N., Hammond, D., Kadia, T. M., Ravandi, F., Chien, K., Van Hyfte, G., Mazumdar, M., Saliba, A., Mangaonkar, A., Lasho, T., Al-Kali, A., Kremyanskaya, M., Feld, J., Silverman, L. R., Komrokji, R. & Mascarenhas, J. & 5 others, , Jan 2025, In: Leukemia. 39, 1, p. 257-260 4 p.Research output: Contribution to journal › Letter › peer-review
4 Scopus citations -
Contemporary Challenges in Polycythemia Vera Management From the Perspective of Patients and Physicians
Kuykendall, A. T., Fine, J. T. & Kremyanskaya, M., Aug 2024, In: Clinical Lymphoma, Myeloma and Leukemia. 24, 8, p. 512-522 11 p.Research output: Contribution to journal › Review article › peer-review
7 Scopus citations -
Conventional Cytogenetic Analysis and Array CGH + SNP Identify Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis Patients Who Are at Risk for Disease Progression
Tripodi, J., Hoffman, R., Tremblay, D., Ahire, D., Mascarenhas, J., Kremyanskaya, M. & Najfeld, V., Apr 2024, In: International Journal of Molecular Sciences. 25, 7, 4061.Research output: Contribution to journal › Article › peer-review
Open Access -
Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse-free survival in acute myeloid leukemia
Balev, M., Zibara, V., Van Hyfte, G., Feld, J., Kremyanskaya, M., Becker, M., Keyzner, A., Shih, A. H., Marcellino, B., Levavi, H., Silverman, L., Mascarenhas, J. & Tremblay, D., Oct 2024, In: American Journal of Hematology. 99, 10, p. 2026-2028 3 p.Research output: Contribution to journal › Letter › peer-review
Press/Media
-
Silence Therapeutics Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting
10/12/24
1 item of Media coverage
Press/Media
-
Silence Therapeutics Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting
10/12/24
3 items of Media coverage
Press/Media
-
Silence Therapeutics Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting
9/12/24
18 items of Media coverage
Press/Media
-
Data on Essential Thrombocythemia Detailed by Researchers at Icahn School of Medicine at Mount Sinai (Conventional Cytogenetic Analysis and Array Cgh Plus Snp Identify Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis Patients Who ...)
Najfeld, V., Hoffman, R., Tremblay, D., Kremyanskaya, M. & Mascarenhas, J.
6/05/24
1 item of Media coverage
Press/Media